As an official media partner, we’re excited to be part of #AIDS2024 in Munich this July.
AIDS 2024 will call on the HIV response to unite behind a simple principle: Put people first! Help spread this message by sharing your experience with #PutPeopleFirst aids2024.org/put-people-fir…

Our April Lancet #HIV 'In conversation with' podcast brings some good news from Botswana. Drew Voetsch and Robert Selato share with us the latest data on the progress of Botswana towards achieving the UNAIDS 95 targets.
Listen here:
buzzsprout.com/1062154/148554…

High acceptability and tolerability of long-acting cabotegravir or rilpivirine injections in the (IMPAACT 2017/MOCHA) trial suggests that these might be favoured treatment options for some adolescents living with #HIV .

thelancet.com/journals/lanhi…

Our April issue is ready! Featuring long-acting ART in adolescents, screening for Gonorrhoeae and Chlamydia during PrEP and Botswana´s achievement of UNAIDS 95-95-95 targets.
thelancet.com/issue/S2352-30…
Cover: ilustratoro (IG) based on this month´s review on Malaria and HIV

Is the term #AIDS still meaningful in the #HIV discourse or it just perpetuates stigma? Language matters and the latest Viewpoint by Isaac Núñez published in our March issue explores the history of this term and debates about its future.
Sergio Iván Valdés, MD, PhD
buff.ly/43lDDdR